Dr Claudie H Jimenez, MD | |
101 N Harrison St, Alexandria, IN 46001-2017 | |
(765) 233-0903 | |
(765) 705-2141 |
Full Name | Dr Claudie H Jimenez |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Addiction Medicine |
Location | 101 N Harrison St, Alexandria, Indiana |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396725693 | NPI | - | NPPES |
Entity Name | Cleanslate Medical Group Of Indiana Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023464294 PECOS PAC ID: 4880963909 Enrollment ID: O20171023001515 |
News Archive
Business and healthcare leaders looking to fast-track preparedness for the H1N1 pandemic are gathering with infectious disease experts and Fortune 500 planners this month to determine how best to protect their employees and preserve their operations.
In a significant advance for HIV prevention research, a clinical trial confirms that the same drugs used for treating HIV can also help prevent HIV infection in the first place.
The Breast Cancer Research Foundation announced the expansion of its research program with a new collaborative breast cancer funding model—the BCRF Investigator-Initiated Drug Research Program—that will help broaden and accelerate clinical research on treatment strategies for people with breast cancer.
Applied Automation Technologies, Inc. and DMG MORI USA Inc. will offer this innovative technology as a solution within the DMG MORI Qualified Products program.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Claudie H Jimenez, MD 8102 Clearvista Parkway, Indianapolis, IN 46256-1661 Ph: (317) 849-8222 | Dr Claudie H Jimenez, MD 101 N Harrison St, Alexandria, IN 46001-2017 Ph: (765) 233-0903 |
News Archive
Business and healthcare leaders looking to fast-track preparedness for the H1N1 pandemic are gathering with infectious disease experts and Fortune 500 planners this month to determine how best to protect their employees and preserve their operations.
In a significant advance for HIV prevention research, a clinical trial confirms that the same drugs used for treating HIV can also help prevent HIV infection in the first place.
The Breast Cancer Research Foundation announced the expansion of its research program with a new collaborative breast cancer funding model—the BCRF Investigator-Initiated Drug Research Program—that will help broaden and accelerate clinical research on treatment strategies for people with breast cancer.
Applied Automation Technologies, Inc. and DMG MORI USA Inc. will offer this innovative technology as a solution within the DMG MORI Qualified Products program.
› Verified 7 days ago